Revolutionizing Alzheimer’s diagnosis: New insights into blood-brain barrier biomarkers
Alzheimer’s disease, the most prevalent form of dementia, involves the disruption of the blood-brain barrier (BBB), a critical defense mechanism of the brain. Recent research has identified unique molecular changes in the BBB that could pave the way for groundbreaking diagnostic and therapeutic approaches. Understanding the blood-brain barrier’s role in Alzheimer’s The BBB is composed […]